Skip to content
    CTVA
    Earnings call· Dec 2024(Q4 FY24)

    Corteva, Inc. CTVA

    Feb 6, 2025 Source

    Executive summary

    Corteva Q4 FY24 — Strong Q4 Performance and Positive 2025 Outlook Despite FX Headwinds

    Corteva concluded FY24 with strong Q4 performance, particularly in Crop Protection, and achieved 20% operating EBITDA margins for the first time. The company provided a positive 2025 outlook, anticipating top and bottom-line growth and margin expansion, driven by strong demand for innovative seed technology and cost improvements. However, significant currency headwinds, primarily from the Brazilian real, are expected to impact reported results, and the Crop Protection market is projected to be flattish with continued pricing pressure.

    Highlights

    5
    • Q4 organic sales increased 13% year-over-year, with Seed up 16% and Crop Protection up 11%.

    • Crop Protection delivered double-digit organic sales growth and 800 basis points of margin improvement in Q4.

    • Operating free cash flow improved by almost $500 million to $1.7 billion in 2024.

    • Achieved 20% operating EBITDA margins for the first time in 2024.

    • Committed to $1 billion in share repurchases in 2025.

    Concerns

    4
    • Q4 pricing was down 4%, largely driven by competitive pressure in Brazil across both Seed and Crop Protection.

    • Full-year Crop Protection organic sales decreased 2% due to price declines.

    • A strong U.S. dollar is expected to result in a low single-digit headwind on net sales and approximately $275 million headwind on operating EBITDA in 2025.

    • Crop Protection prices are expected to be down low single digits for the full year 2025.

    Guidance & targets

    15
    CategoryTargetConfidence
    Operating EBITDA
    $3.6B-$3.8B
    high materiality
    High
    Operating EPS
    $2.70-$2.95
    high materiality
    High
    Free cash flow to EBITDA conversion rate
    40%-45%
    medium materiality
    Medium
    Share repurchases
    $1B
    high materiality
    High
    Total company pricing
    flat to up low single digits
    medium materiality
    Medium
    Crop Protection pricing
    down low single digits
    medium materiality
    Medium
    Crop Protection volume growth
    up mid-single digits
    medium materiality
    Medium
    Net royalty expense improvement
    $50M
    medium materiality
    High
    Net cost improvements
    $400M
    high materiality
    High
    Operating EBITDA margin expansion
    100-150 bps
    high materiality
    High
    Incremental net revenues from growth platforms
    $1B
    high materiality
    High
    Gross productivity cost and deflation benefits
    $1B
    high materiality
    High
    EBITDA margin growth
    100 bps per year
    high materiality
    High
    EBITDA growth
    $1B
    high materiality
    High
    EBITDA margins
    23%-24%
    high materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Seed
    Consistently delivered in 2024, gaining corn market share in North America with solid pricing. Latin America experienced a competitive market and high-cost inventory in Q4, but the COGS position is expected to materially improve in 2025 with pricing opportunities. Expected to have another strong year in 2025, driven by more corn acres in North America and share gains.
    FY24 Organic Sales Growth: 4%FY24 Pricing Growth: 3%FY24 Volume Growth: 1%Pioneer Rank: #1 corn and soybean brand in U.S.Enlist E3 Soybeans Market Penetration: 65%Enlist System Sales: $1.9B in 2024
    16%
    Crop Protection
    Delivered double-digit organic sales growth and significant margin improvement in Q4, largely attributable to demand in Brazil. Full-year organic sales were down due to price decline, primarily from competitive dynamics in Latin America. New products and spinosyns delivered double-digit volume gains in 2024. Q4 was a record quarter, driven by biologicals, new products, spinosyns, and higher-margin fungicides/insecticides. $170M cost reduction in Q4 year-over-year.
    FY24 Organic Sales Growth: -2%FY24 Pricing Growth: -5%FY24 Volume Growth: 3%Q4 Volume Growth: 16% (led by Latin America and EMEA)New Products Volume Growth: >20% in Q4Biologicals Volume Growth: Mid-single-digit in 2024
    11%800 bps improvement

    Operational metrics

    15
    Operating EBITDA margin
    20%30 bps higher
    FY24

    Achieved for the first time in 2024, more than 30 basis points higher than prior year.

    Share repurchases and dividends
    $1.5B
    FY24

    Returned to shareholders via dividends and share repurchases for the full year.

    Net royalty expense improvement
    $155M
    FY24

    Benefit from lower net royalty expense.

    Raw material deflation and productivity actions benefit
    $220M
    FY24

    Benefit from raw material deflation and productivity actions.

    R&D expense as percentage of sales
    just over 8%
    FY24

    In line with expectations for the full year.

    Currency headwind on operating EBITDA
    $275M
    FY25

    Expected headwind due to stronger U.S. dollar, largely driven by Brazilian real, Turkish lira, and Canadian dollar.

    Currency headwind on net sales
    low single-digit
    FY25

    Expected headwind due to stronger U.S. dollar.

    Biologicals revenue target
    $1B
    by end of decade

    Targeted revenue by the end of the decade.

    Enlist system sales
    $1.9B
    2024

    Sales for the Enlist system, including herbicide offerings.

    Crop Protection cost reduction program
    $200M
    FY25

    Amount of cost reduction expected in 2025, part of a $300M run rate commitment by 2027.

    Crop Protection raw material deflation
    $100M
    FY24

    Benefit from raw material deflation in 2024, expected to continue into 2025.

    Core working capital tailwind
    $300M
    FY24

    Tailwind from receivables, inventory, and payables.

    Core working capital headwind
    $100M
    FY25

    Expected headwind, returning to more normal levels.

    Cash balance
    $3.1M
    end of FY24

    Higher than typical cash balance at year-end.

    China COGS exposure
    2%
    current

    Percentage of Crop Protection Cost of Goods Sold (COGS) sourced from China, with 80% of that being multi-sourced.

    Industry KPIs

    2
    MetricValueDetails
    Volume vs price splitTotal company pricing flat to up low single digits%
    Productivity cost savings program$1BUSD

    Product announcements

    1
    ProductTypeDetails
    New seed hybrids and varietieslaunch

    Risks & headwinds

    3
    Strong U.S. dollar / Currency headwindsFY25

    Approximately $275 million headwind on operating EBITDA in 2025; low single-digit headwind on net sales. Primarily Brazilian real, Turkish lira, and Canadian dollar.

    Mitigation: Looking for opportunities to mitigate additional volatility through pricing and other means. Hedging practices are within the year for the year.

    Crop Protection pricing pressureFY25, with more pressure in H1, flattening in H2.

    Expected to be down low single digits for FY25.

    Mitigation: Stabilization of channel inventories, focus on new products and biologicals, and cost reduction programs.

    Competitive market in Latin America SeedQ4 FY24, expected to improve in 2025.

    Pricing down in Q4 FY24 due to competitive market and high-cost inventory.

    Mitigation: Improved COGS position in Brazil for 2025, pricing opportunity with new products and better technology, and strong demand for differentiation and yield.

    What to watch in Q1 FY25

    4

    Crop Protection market stabilization and pricing

    Next quarter / H1 2025
    CurrentFlattish market assumed for 2025, low single-digit negative pricing expected for FY25 (more in H1).
    TargetPricing environment stabilization, potential for market rebound.

    Why it matters

    Determines the upper end of 2025 guidance and overall CP segment profitability, indicating industry recovery.

    Given what we know today, this seems to be the most reasonable assumption for the time being, and we'll continue to update the market as conditions evolve.

    Q&A highlights

    7

    How do potential positives in the Seed business (e.g., increased corn acres, PowerCore performance, pricing) balance against FX headwinds in the 2025 guidance?

    Management acknowledged improved market fundamentals (strong crop demand, higher crop prices, tight corn stocks-to-use ratios, improving farmer margins) and stabilizing CP industry conditions. They reiterated the $275M FX headwind but highlighted $400M in self-help benefits. The 10% midpoint EBITDA growth is considered a balanced set of assumptions, with the CP market's pricing stabilization being a key factor.

    I think for us, probably one of the big pluses and minuses is just the CP industry in general, which we talked about, we expect some low single-digit negative pricing in the CP business this year in 2025, which is a pretty significant improvement over what we saw in 2024.

    asked by Christopher Parkinson · answered by David Johnson

    3 min read6 chapters

    Detailed Narrative

    01

    Q4 Performance Highlights

    Corteva concluded FY24 with a strong fourth quarter, achieving 13% year-over-year organic sales growth. This was driven by robust performance in both the Seed segment, which grew 16%, and the Crop Protection segment, which saw an 11% increase. Notably, Crop Protection delivered double-digit organic sales growth and an impressive 800 basis points of margin improvement in Q4, largely attributed to strong demand for its technology in Brazil. The Seed business consistently performed well throughout 2024, with Pioneer maintaining its leading position in the U.S. corn and soybean markets and gaining North American corn market share.

    02

    Market Fundamentals and 2025 Outlook

    Overall agricultural fundamentals remain constructive, supported by record global consumption of corn and soybeans in 2024, with continued growth expected in 2025. Crop prices are rebounding, and U.S. farmers achieved back-to-back record corn yields. The corn market is particularly tight, with global stocks-to-use ratios at their lowest in over a decade, indicating a strong demand signal for increased corn acreage. The Crop Protection industry is showing signs of stabilization, with channel inventories becoming more balanced and pricing from China stabilizing. For 2025, Corteva assumes a flattish CP market with low single-digit volume gains offset by low single-digit pricing headwinds.

    03

    Cost and Productivity Initiatives

    In 2024, Corteva realized nearly $500 million in self-help benefits, including $155 million from lower net royalty expense and $220 million from raw material deflation and productivity actions. For 2025, the company is targeting $550 million in gross cost and sales improvements, including an additional $50 million from royalty improvements, leading to $400 million in net cost improvements. These initiatives, which include Crop Protection footprint optimization, are central to driving meaningful margin expansion and supporting the company's financial targets.

    04

    Strategic Growth Platforms and 2027 Framework

    Corteva's 2027 financial framework targets $1 billion in incremental net revenues from three key growth platforms: increased out-licensing income, continued ramp-up of new Crop Protection products, and biologicals growth. The company also aims for $1 billion in gross productivity, cost, and deflation benefits through its 'controlling the controllables' program. These efforts are expected to drive approximately 100 basis points of EBITDA margin growth per year, culminating in 23-24% EBITDA margins and $1 billion in EBITDA growth over the 2025-2027 period.

    05

    Currency Headwinds and Mitigation

    A significant headwind for 2025 is the strong U.S. dollar, primarily impacting results through the Brazilian real, Turkish lira, and Canadian dollar. This is projected to result in a low single-digit headwind on net sales and approximately $275 million headwind on operating EBITDA. Management is actively seeking opportunities to mitigate this volatility through pricing strategies and other means, noting that their hedging practices are typically within the year for the year.

    06

    Seed Business Strength and Innovation

    The Seed business is poised for another strong year in 2025, driven by an expected increase in corn acres in North America and continued market share gains. Margin improvement is anticipated from mix uplift, royalty income enhancements, and cost of sales benefits, including productivity and deflation. Corteva plans to launch 300 new seed hybrids and varieties, leveraging its robust pipeline and 'price for value' strategy, with the Enlist E3 soybean system already achieving 65% market penetration.

    AI-generated summary of the company’s earnings call. Not investment advice.